Osteoporosis drug stops growth of breast cancer cells

Osteoporosis drug stops growth of breast cancer cells

A drug approved in Europe to treat osteoporosis has now been shown to stop the growth of breast cancer cells, even in cancers that have become resistant to current targeted therapies, according to a Duke Cancer Institute study. The drug bazedoxifene packs a powerful one-two punch that not only prevents estrogen from fueling breast cancer, but also flags the estrogen receptor from destruction.

Read More